Uncategorised - European Medical Journal

Portable Spacer Solutions for Respiratory Care

In this short on demand video, Alan Kaplan and Job F.M. VanBoven discuss the AeroChamber2go* spacer and the potential benefits to the…

Review of the European Association for Haemophilia and Allied Disorders (EAHAD) 19th Annual Congress

IN the vibrant city of Dublin, Ireland, over 2,000 delegates from over 77 countries gathered for the 19th annual European Association for…

The History of Von Willebrand Disease

The first case of VWD was described and published in 1926 by Erik von Willebrand. Therefore, 2026 marks its centenary anniversary…

Von Willebrand Disease: 100 Years of Progress and New Horizons

The 2026 Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) placed special emphasis on the centenary…

EAHAD 2026 Interview: Ana Boban

We had the pleasure of speaking with Ana Boban, President of the European Association for Haemophilia and Allied Disorders…

Sleeping man with his mouth slightly ajar, similar to a snoring position. His wife is awake behind him, hands up in the air from frustration.

Sleep Apnea Prevalent in Newly Diagnosed Lung Cancer

Obstructive sleep apnea affected nearly half of never-smokers with newly diagnosed lung cancer in this prospective study.

Stethoscope resting on a notebook, representing healthcare education and training

Metaverse Training Strengthens Infectious Disease Preparedness

Metaverse based infectious disease training improved engagement and self-directed learning for school nurses in this qualitative study.

Baseball, bat and glove on the grass

AbbVie to sponsor leading US baseball league

This collaboration marks the first of its kind for AbbVie and signals a massive national expansion of its ‘Striking Out Cancer’ initiative.

Heart Failure Drives Mortality After PCI

Heart failure hospitalisation was associated with a markedly increased risk of death (adjusted hazard ratio [HR]: 6.11), far exceeding that of ACS (HR: 3.22) and major bleeding (HR: 2.62).

Biomarkers May Predict Flares During RA Treatment Tapering

Trial shows clinical and molecular biomarkers can predict flare risk in rheumatoid arthritis during biologic tapering, supporting personalised treatment strategies.